Zoetis Expands Nebraska Drug Factory

The Lincoln, Neb., plant makes many animal drugs and vaccines, including Rimadyl, Bovi-Shield Gold and Synovex.

From left, Zoetis vice president Jon Lowe, Mayor Chris Beutler and site leader Betty Mason cut a ribbon to mark the completion of a 19,000-square-foot, three-story expansion of the Zoetis Global Manufacturing and Supply plant in Lincoln, Neb.

A Zoetis Inc. plant that makes Rimadyl (carprofen) for dogs along with a variety of other animal drugs and vaccines has undergone a 19,000-square-foot expansion.

A ribbon-cutting ceremony was held Aug. 20 at the Lincoln, Neb., factory, which employs 500 people and has room for an additional 30 at peak production times.

“Zoetis is excited to expand its footprint in Lincoln and provide veterinarians, livestock producers, pet owners and the animals in their care with a reliable, consistent supply of quality animal health products,” said Zoetis site leader Betty Mason. “The entire community can be proud of our expanded manufacturing operations, which enable us to produce 1,200 finished goods for more than 100 markets around the world.”

Zoetis, based in Florham Park, N.J., makes a number of flagship products in Lincoln. Among them are the pain medication Rimadyl, the livestock vaccines Bovi-Shield Gold and Respi-Sure One, and a swine vaccine formulated to fight porcine epidemic diarrhea virus.

The expansion will allow for full production of the beef cattle weight-gain drug Synovex and the manufacture of the new Canine Atopic Dermatitis Immunotherapeutic, which is scheduled to roll out later this year.

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *